Table 1.
Patients’ characteristics (whole study group).
| Female | Male | All Cases | |
|---|---|---|---|
| 76 (45.51%) | 91 (54.49%) | 167 (100%) | |
| Age | 66.63 ± 9.48 | 63.75 ± 9.46 | 65.09 ± 9.55 |
| Tumour localization | |||
| Left-sided | 49 (66.22%) | 65 (73.86%) | 114 (70.37%) |
| Right-sided | 25 (33.78%) | 23 (26.13%) | 48 (29.63%) |
| T parameter | |||
| T1 | 1 (1.33%) | 7 (8.05%) | 8 (4.94%) |
| T2 | 16 (21.33%) | 12 (13.79%) | 28 (22.22%) |
| T3 | 47 (62.67%) | 54 (62.07%) | 101 (62.35%) |
| T4 | 11 (14.67%) | 14 (16.09%) | 25 (15.43%) |
| N parameter | |||
| N0 | 32 (42.67%) | 37 (42.05%) | 69 (42.33%) |
| N1 | 30 (40.00%) | 37 (42.05%) | 67 (41.10%) |
| N2 | 13 (17.33%) | 14 (15.91%) | 27 (16.56%) |
| M parameter | |||
| M0 | 66 (88.00%) | 69 (79.31%) | 135 (83.33%) |
| M1 | 9 (12.00%) | 18 (20.69%) | 27 (16.67%) |
| TNM stage | |||
| I | 13 (17.33%) | 13 (14.77%) | 26 (15.95%) |
| II | 19 (25.33%) | 21 (28.86%) | 40 (24.54%) |
| III | 34 (45.33%) | 37 (42.05%) | 71 (43.55%) |
| IV | 9 (12.00%) | 17 (19.32%) | 26 (15.95%) |
| Grading | |||
| Low | 63 (85.14%) | 75 (85.23%) | 138 (85.16%) |
| High | 11 (14.86%) | 13 (14.777%) | 24 (14.81%) |
| Adjuvant treatment | |||
| Yes | 7 (9.21%) | 14 (15.38%) | 21 (12.35%) |
| No | 69 (90.79%) | 77 (84.62%) | 149 (87.65%) |